Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma

This study is ongoing, but not recruiting participants.

Study NCT00070291 Information provided by National Cancer Institute (NCI)

First Received: October 3, 2003 Last Updated: April 14, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	November 2017 (Final data collection date for primary outcome measure)